West Pharmaceutical Servs (NYSE:WST) just reported results for the first quarter of 2024.
- West Pharmaceutical Servs reported earnings per share of $1.56. This was above the analyst estimate for EPS of $1.26.
- The company reported revenue of $695.40 million.
- This was 3.74% better than the analyst estimate for revenue of $670.30 million.